InSphero and Path BioAnalytics Announce Partnership to Develop Advanced 3D Airway Tissue Model for Cystic Fibrosis Research
19 déc. 2018 03h59 HE
|
InSphero AG
Schlieren, Switzerland, Dec. 19, 2018 (GLOBE NEWSWIRE) -- InSphero AG and Path BioAnalytics today announced a partnership through which Path BioAnalytics will produce and test 3D cystic fibrosis...